account_id none on file
legal_name Silo Pharma, Inc.
ticker SILO
cik 1514183
domain silopharma.com
linkedin_company_url https://www.linkedin.com/company/silopharma
entry_point_account_id none on file
name Silo Pharma Inc.
exchange Nasdaq
sector Consumer Discretionary
hq Sarasota, FL, United States
sector index/company/sector/consumer-discretionary/
calls 0 filings 4 executives 3 family 0
why_nownone on file
callsnone on file
filings
On September 27, 2022, the Board appointed Daniel Ryweck as Chief Financial Officer of the Company. On September 28, 2022, the Company entered into an employment agreement (the “Ryweck Employment Agreement”) with Mr.
filing / Aug 13, 2026 / receipt
reasonable travel expenses to attend board and committee meetings, reasonable outside seminar expenses, and other special board related
filing / Jun 30, 2026 / receipt
Board appointed Daniel Ryweck as Chief Financial Officer of the Company. On September 28, 2022, the Company entered into an employment
filing / Jun 30, 2026 / receipt
extra convenience for shareholders and cost savings for companies. Stockholders who participate in householding will continue to be able
filing / Jun 30, 2026 / receipt
executives
| Daniel Ryweck | Chief Financial Officer | - | receipt |
| Kevin Mu | director | - | receipt |
| Richard A. Brand | Chairman | - | receipt |
familynone on file
upcoming
| 2026-11-12 | earnings call | scheduled | ir |
changes
| 2022-09-30 | Chief Financial Officer, appointed | sec_8k |
| 2020-10-06 | director, appointed | sec_8k |
| 2018-06-01 | Chief Financial Officer, departed | sec_8k |
| 2015-11-27 | Chairman, departed | sec_8k |
| 2015-07-24 | Chief Financial Officer, appointed | sec_8k |
| 2015-07-24 | Chief Financial Officer, departed | sec_8k |
| 2013-01-30 | Chairman, appointed | sec_8k |
| 2013-01-30 | Vice President, departed | sec_8k |
mcp_package_hint
slug silo-pharma-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$